| # | Drug | Count |
|---|---|---|
| 0 | TENOFOVIR DISOPROXIL FUMARATE | 578 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 369 |
| 2 | LAMIVUDINE | 261 |
| 3 | LAMIVUDINE ORAL | 211 |
| 4 | RITONAVIR | 162 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 152 |
| 6 | LOPINAVIR AND RITONAVIR | 121 |
| 7 | ADEFOVIR DIPIVOXIL | 101 |
| 8 | ATAZANAVIR | 101 |
| 9 | BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 101 | 0.0795 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 152 | 0.0176 |
| 2 | RALTEGRAVIR | 69 | 0.0131 |
| 3 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 6 | 0.0128 |
| 4 | LAMIVUDINE | 261 | 0.0103 |
| 5 | DARUNAVIR ETHANOLATE AND COBICISTAT | 18 | 0.0102 |
| 6 | LOPINAVIR AND RITONAVIR | 121 | 0.0090 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 369 | 0.0081 |
| 8 | NELFINAVIR MESYLATE | 15 | 0.0072 |
| 9 | ATAZANAVIR | 101 | 0.0071 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antidiarrheal [EPC] | 2 | 0.0084 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 329 | 0.0067 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 712 | 0.0065 |
| 3 | Protease Inhibitor [EPC] | 280 | 0.0063 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 357 | 0.0059 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 9 | 0.0039 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 92 | 0.0038 |
| 7 | Iron Chelator [EPC] | 51 | 0.0017 |
| 8 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 9 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |